Literature DB >> 17417783

Second neoplasms after oesophageal cancer.

Fabio Levi1, Lalao Randimbison, Manuela Maspoli, Van-Cong Te, Carlo La Vecchia.   

Abstract

The authors considered the incidence of second neoplasms among 1,672 oesophageal cancers diagnosed between 1974 and 2004 in the Cancer Registries of the Swiss Cantons of Vaud and Neuchâtel, and followed-up to 2004. A total of 141 second neoplasms were observed versus 38.5 expected, corresponding to a standardized incidence ratio (SIR) of 3.7 (95% confidence interval: 3.1-4.3). The SIRs were statistically significant for cancers of the oral cavity and pharynx (57.3), larynx (24.3), lung (6.6) and intestines (2.6). The SIRs were higher in subjects diagnosed below age 50 and in the first year after diagnosis. The SIR of upper digestive and respiratory tract neoplasms was higher for oesophageal cancers diagnosed in the upper (87.5) and middle (68.1), as compared with the lower third (19.4). There was no rise of second oral, pharyngeal and laryngeal cancer with advancing age, and their incidence tended indeed to decline from 100/1,000 at age 40-49 to 25/1,000 at age 70-79. There was no tendency to rise with age in the incidence of first oesophageal cancer in subjects who subsequently developed another upper digestive or respiratory tract neoplasm. The excess risks of upper digestive and respiratory tract neoplasms are attributable to increased diagnosis and registration of second neoplasms following a diagnosis of oesophageal cancer, as well as to heavy tobacco and alcohol consumption in oesophageal cancer cases. The absence of rise in incidence with age is also compatible with the existence of a subset of the population of susceptible individuals. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17417783     DOI: 10.1002/ijc.22744

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries.

Authors:  Cristina Bosetti; Ghislaine Scelo; Shu-Chun Chuang; Jon M Tonita; Sharon Tamaro; Jon G Jonasson; Erich V Kliewer; Kari Hemminki; Elisabete Weiderpass; Eero Pukkala; Elizabeth Tracey; Jorgen H Olsen; Vera Pompe-Kirn; David H Brewster; Carmen Martos; Kee-Seng Chia; Paul Brennan; Mia Hashibe; Fabio Levi; Carlo La Vecchia; Paolo Boffetta
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

2.  Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population.

Authors:  Steffi E M van de Ven; Janne M Falger; Rob H A Verhoeven; Robert J Baatenburg de Jong; Manon C W Spaander; Marco J Bruno; Arjun D Koch
Journal:  United European Gastroenterol J       Date:  2021-03-29       Impact factor: 4.623

3.  Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma.

Authors:  Guoqing Zhang; Bin Wu; Xiaofei Wang; Jindong Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.